All stock lists
Evotec SE (Deutsche Börse:EVT.DE)
DE · Delayed Price · Currency is EUR
Also listed: 0IRF.IL, EVOTF, EVT.SWHealthcare · Drug Manufacturers - Specialty & Generic
2.80-0.01 (-0.28%)
Insider Score
––Not scored
EVT.DE Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
EVT.DE Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 143.48 M | 156.64 M | 253.27 M | 163.89 M | 171.24 M | 199.98 M |
| Revenue Growth (YoY) | -16.21 % | -21.67 % | 14.49 % | -11.36 % | -5.98 % | -4.19 % |
| Cost of Revenue | 145.06 M | 158.21 M | 174.81 M | 163.95 M | 162.64 M | 172.75 M |
| Gross Profit | -1.58 M | -1.57 M | 78.46 M | -62.00 K | 8.59 M | 27.23 M |
| SG&A Expense | 39.29 M | 43.79 M | 44.35 M | 42.31 M | 41.61 M | 47.70 M |
| R&D Expense | 10.26 M | 10.08 M | 9.83 M | 8.71 M | 8.21 M | 10.76 M |
| Operating Expenses | 49.55 M | 53.87 M | 54.18 M | 44.44 M | 36.37 M | 47.23 M |
| Operating Income | -51.13 M | -55.44 M | 24.28 M | -44.50 M | -27.77 M | -20.01 M |
| Pretax Income | -48.12 M | -122.18 M | 29.46 M | -42.96 M | -43.42 M | -29.85 M |
| Tax Provision | -1.47 M | -244.00 K | 14.84 M | 127.00 K | 59.00 K | 1.73 M |
| Net Income | -46.65 M | -121.94 M | 14.62 M | -43.09 M | -43.48 M | -31.58 M |
| EPS (Basic) | -0.26 | -0.69 | 0.08 | -0.24 | -0.24 | -0.18 |
| EPS (Diluted) | -0.26 | -0.69 | 0.08 | -0.24 | -0.24 | -0.18 |
| Shares Outstanding | 177.76 M | 177.56 M | 177.74 M | 177.67 M | 177.60 M | 177.53 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.
